KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Change in Cash (2016 - 2025)

Historic Change in Cash for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $143.5 million.

  • Opko Health's Change in Cash fell 6219.15% to $143.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year decrease of 9687.01%. This contributed to the annual value of $349.7 million for FY2024, which is 71024.95% up from last year.
  • As of Q3 2025, Opko Health's Change in Cash stood at $143.5 million, which was down 6219.15% from -$164.3 million recorded in Q2 2025.
  • Opko Health's Change in Cash's 5-year high stood at $379.5 million during Q3 2024, with a 5-year trough of -$164.3 million in Q2 2025.
  • Its 5-year average for Change in Cash is $18.8 million, with a median of -$13.9 million in 2021.
  • Within the past 5 years, the most significant YoY rise in Opko Health's Change in Cash was 114369.61% (2024), while the steepest drop was 118813.37% (2024).
  • Over the past 5 years, Opko Health's Change in Cash (Quarter) stood at -$13.9 million in 2021, then tumbled by 99.06% to -$27.6 million in 2022, then tumbled by 54.59% to -$42.7 million in 2023, then skyrocketed by 159.78% to $25.5 million in 2024, then skyrocketed by 461.56% to $143.5 million in 2025.
  • Its Change in Cash was $143.5 million in Q3 2025, compared to -$164.3 million in Q2 2025 and $4.1 million in Q1 2025.